Zobrazeno 1 - 4
of 4
pro vyhledávání: '"E. V. Usikova"'
Autor:
E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 12, Iss 6, Pp 64-77 (2023)
Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leu
Externí odkaz:
https://doaj.org/article/0b6810be75d24a37be9a671bc5da96a4
Autor:
O. Yu. Vinogradova, M. M. Pankrashkina, D. I. Shikhbabaeva, M. V. Chernikov, A. L. Neverova, V. L. Ivanova, E. A. Nikitin, E. V. Usikova, V. V. Ptushkin
Publikováno v:
Онкогематология, Vol 17, Iss 4, Pp 94-105 (2022)
Background. For many years the primary aim of treatment strategy for ph-negative myeloproliferative neoplasms has been to restrain disease progression, with lasting relief and management of symptoms to improve patients’ quality of life. Generally,
Externí odkaz:
https://doaj.org/article/12385d86efa6423ebfe6e5d6fce6e692
Autor:
E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Publikováno v:
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 12:64-77
Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62dd43a459e423a2066f90600fd9d1ce
https://doi.org/10.20340/vmi-rvz.2022.6.clin.5
https://doi.org/10.20340/vmi-rvz.2022.6.clin.5
Autor:
O M Koroleva, E. Mikhaltsova, Larisa A. Kuzmina, M Y Drokov, Valeriy G. Savchenko, E V Usikova, V. A. Vasileva, Elena N. Parovichnikova, A. A. Dmitrova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 1, Pp 89-94 (2019)
Aim. To assess the rehospitalization data of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT), to determine possible risk factors for rehospitalization, and to work out a strategy of post-transplantation follow-up for thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963715d1af8f3607e1948da96f6849cb
https://doi.org/10.21320/2500-2139-2020-13-1-89-94
https://doi.org/10.21320/2500-2139-2020-13-1-89-94